 ABC Action News | Bristol-Myers Squibb Higher Ahead of Earnings TradersHuddle.com The Company offers products and experimental therapies to address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. Other companies on the watch on this earnings event are ... CITIGROUP RAISED ITS PT FOR BRISTOL-MYERS SQUIBB TO $40 (BMY) |
